OBALON THERAPEUTICS INC·4

Aug 27, 9:32 PM ET

Plovanic William J. 4

4 · OBALON THERAPEUTICS INC · Filed Aug 27, 2018

Insider Transaction Report

Form 4
Period: 2018-08-23
Plovanic William J.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2018-08-23$1.82/sh+27,472$49,999293,044 total
Footnotes (2)
  • [F1]The reporting person purchased these shares directly from the issuer in a private placement.
  • [F2]Includes Restricted Shares that are subject to vesting.

Documents

1 file
  • 4
    marketforms-42784.xmlPrimary

    PRIMARY DOCUMENT